{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:53:38Z","timestamp":1790013218349,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.cll.2025.01.012","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T19:00:01Z","timestamp":1741892401000},"page":"295-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Detection of Fentanyl and Fentanyl Analogs"],"prefix":"10.1016","volume":"45","author":[{"given":"Bridgit O.","family":"Crews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cll.2025.01.012_bib1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1213\/00000539-197007000-00003","article-title":"Fentanyl in anesthesia: a report of 500 cases","volume":"49","author":"Grell","year":"1970","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.cll.2025.01.012_bib2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00000542-199902000-00034","article-title":"A review of the use of fentanyl analgesia in the management of acute pain in adults","volume":"90","author":"Peng","year":"1999","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.cll.2025.01.012_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/wps.20846","article-title":"The epidemic of fentanyl misuse and overdoses: challenges and strategies","volume":"20","author":"Volkow","year":"2021","journal-title":"World Psychiatry"},{"issue":"Pt A","key":"10.1016\/j.cll.2025.01.012_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","article-title":"Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review","volume":"134","author":"Armenian","year":"2018","journal-title":"Neuropharmacology"},{"issue":"29","key":"10.1016\/j.cll.2025.01.012_bib5","first-page":"793","article-title":"Nonpharmaceutical fentanyl-related deaths--multiple states, April 2005-March 2007","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.cll.2025.01.012_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7812\/TPP\/22.176","article-title":"Strategies to reduce harm: an expert panel discussion on the fentanyl crisis","volume":"27","author":"Leitz","year":"2023","journal-title":"Perm J"},{"issue":"18","key":"10.1016\/j.cll.2025.01.012_bib8","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMp2308525","article-title":"Scaling up point-of-care fentanyl testing \u2014 a step forward","volume":"389","author":"Barnett","year":"2023","journal-title":"N Engl J Med"},{"issue":"43","key":"10.1016\/j.cll.2025.01.012_bib12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.15585\/mmwr.mm6643e1","article-title":"Deaths involving fentanyl, fentanyl analogs, and U-47700 \u2014 10 States, July\u2013December 2016","volume":"66","author":"O\u2019Donnell","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cll.2025.01.012_bib13","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6910a4","article-title":"Notes from the field: opioid-involved overdose deaths with fentanyl or fentanyl analogs detected \u2014 28 States and the District of Columbia, July 2016\u2013December 2018","volume":"69","author":"O\u2019Donnell","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cll.2025.01.012_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01210","article-title":"Postmortem toxicology of new synthetic opioids","volume":"9","author":"Concheiro","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cll.2025.01.012_bib15","article-title":"Novel psychoactive substances: types, mechanisms of action, and effects","volume":"356","author":"Tracy","year":"2017","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.cll.2025.01.012_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1373\/clinchem.2017.281626","article-title":"The fentanyl epidemic and evolution of fentanyl analogs in the United States and the European Union","volume":"65","author":"Jannetto","year":"2019","journal-title":"Clin Chem"},{"issue":"5","key":"10.1016\/j.cll.2025.01.012_bib17","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00414-014-1040-y","article-title":"Quantitative low-volume assay for simultaneous determination of fentanyl, norfentanyl, and minor metabolites in human plasma and urine by liquid chromatography\u2014tandem mass spectrometry (LC-MS\/MS)","volume":"128","author":"Mahlke","year":"2014","journal-title":"Int J Leg Med"},{"issue":"3","key":"10.1016\/j.cll.2025.01.012_bib18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1213\/00000539-199303000-00030","article-title":"An analysis of the duration of fentanyl and its metabolites in urine and saliva","volume":"76","author":"Silverstein","year":"1993","journal-title":"Anesth Analg"},{"key":"10.1016\/j.cll.2025.01.012_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108147","article-title":"Protracted renal clearance of fentanyl in persons with opioid use disorder","volume":"214","author":"Huhn","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.cll.2025.01.012_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108264","article-title":"Fentanyl analog positivity among near-real-time urine drug test results in patients seeking health care","volume":"217","author":"Stanton","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.cll.2025.01.012_bib23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1520\/JFS13045J","article-title":"Fentanyl-related deaths: demographics, circumstances, and toxicology of 112 cases","volume":"36","author":"Henderson","year":"1991","journal-title":"J Forensic Sci"},{"issue":"1","key":"10.1016\/j.cll.2025.01.012_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1520\/JFS13581J","article-title":"A fentanyl epidemic in Maryland 1992","volume":"39","author":"Smialek","year":"1994","journal-title":"J Forensic Sci"},{"issue":"11\u201312","key":"10.1016\/j.cll.2025.01.012_bib25","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.cca.2011.01.029","article-title":"A new automated urine fentanyl immunoassay: technical performance and clinical utility for monitoring fentanyl compliance","volume":"412","author":"Snyder","year":"2011","journal-title":"Clin Chim Acta Int J Clin Chem"},{"issue":"1","key":"10.1016\/j.cll.2025.01.012_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.forsciint.2010.07.022","article-title":"Development of a homogeneous immunoassay for the detection of fentanyl in urine","volume":"206","author":"Wang","year":"2011","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.cll.2025.01.012_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jmsacl.2023.02.009","article-title":"Evaluating the performance of the Roche FEN2 fentanyl immunoassay and its clinical implementation: the role of LDT-based mass spectrometry testing","volume":"28","author":"Menlyadiev","year":"2023","journal-title":"J Mass Spectrom Adv Clin Lab"},{"issue":"5","key":"10.1016\/j.cll.2025.01.012_bib28","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/jalm\/jfab033","article-title":"Performance evaluation of an automated fentanyl immunoassay","volume":"6","author":"Tang","year":"2021","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.cll.2025.01.012_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/jalm\/jfae036","article-title":"Performance of a norfentanyl immunoassay in specimens with low concentrations of fentanyl and\/or norfentanyl","author":"Uljon","year":"2024","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.cll.2025.01.012_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/jalm\/jfae022","article-title":"Performance of fentanyl immunoassays in an ED patient population","author":"Mills","year":"2024","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.cll.2025.01.012_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/jalm\/jfae056","article-title":"Performance evaluation of 2 FDA-approved fentanyl immunoassays against LC-MS\/MS Reference","author":"Militello","year":"2024","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.cll.2025.01.012_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/jalm\/jfae049","article-title":"A comparative analysis of two commonly used FDA-approved immunoassays for fentanyl detection","author":"Lam","year":"2024","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.cll.2025.01.012_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/jalm\/jfae059","article-title":"Evaluation of a rapid drug test device for urine fentanyl compared to mass spectrometry and 2 urine fentanyl assays","author":"Laryea","year":"2024","journal-title":"J Appl Lab Med"},{"issue":"1","key":"10.1016\/j.cll.2025.01.012_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12954-018-0276-0","article-title":"Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study","volume":"16","author":"Goldman","year":"2019","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.cll.2025.01.012_bib36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugpo.2018.08.007","article-title":"Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the Southeastern United States","volume":"63","author":"Peiper","year":"2019","journal-title":"Int J Drug Pol"},{"key":"10.1016\/j.cll.2025.01.012_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108300","article-title":"Drug checking identifies counterfeit alprazolam tablets","volume":"218","author":"Tobias","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.cll.2025.01.012_bib38","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/jalm\/jfaa048","article-title":"Comparison of two commercially available fentanyl screening immunoassays for clinical use","volume":"5","author":"Budelier","year":"2020","journal-title":"J Appl Lab Med"},{"issue":"9","key":"10.1016\/j.cll.2025.01.012_bib39","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jat\/bku103","article-title":"Cross-reactivity of acetylfentanyl and risperidone with a fentanyl immunoassay","volume":"38","author":"Wang","year":"2014","journal-title":"J Anal Toxicol"},{"issue":"6","key":"10.1016\/j.cll.2025.01.012_bib40","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/jalm\/jfac065","article-title":"An opioid hiding in plain sight: loperamide-induced false-positive fentanyl and buprenorphine immunoassay results","volume":"7","author":"Geno","year":"2022","journal-title":"J Appl Lab Med"},{"issue":"3","key":"10.1016\/j.cll.2025.01.012_bib41","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/clinchem\/hvad002","article-title":"Unexpected fentanyl detection during a liver transplant evaluation","volume":"69","author":"Fitch","year":"2023","journal-title":"Clin Chem"},{"issue":"6","key":"10.1016\/j.cll.2025.01.012_bib42","article-title":"False-positive fentanyl urine detection after initiation of labetalol treatment for hypertension in pregnancy: a case report","volume":"16","author":"Wanar","year":"2022","journal-title":"J Addiction Med"},{"issue":"5","key":"10.1016\/j.cll.2025.01.012_bib43","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.japh.2022.05.011","article-title":"A false positive fentanyl result on urine drug screen in a patient treated with ziprasidone","volume":"62","author":"Waters","year":"2022","journal-title":"J Am Pharmaceut Assoc"},{"issue":"4","key":"10.1016\/j.cll.2025.01.012_bib44","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/jat\/bkab033","article-title":"ELISA screens for fentanyl in urine are susceptible to false-positives in high concentration methamphetamine samples","volume":"46","author":"Abbott","year":"2022","journal-title":"J Anal Toxicol"},{"issue":"2","key":"10.1016\/j.cll.2025.01.012_bib45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/jat\/bkaa181","article-title":"Detection of 30 fentanyl analogs by commercial immunoassay kits","volume":"45","author":"Wharton","year":"2021","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.cll.2025.01.012_bib46","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fphar.2019.00238","article-title":"Metabolic pathways and potencies of new fentanyl analogs","volume":"10","author":"Wilde","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cll.2025.01.012_bib47","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-0716-3541-4_26","article-title":"Quantitative assay of fentanyl and analogs using LC-MS\/MS","volume":"2737","author":"Brown","year":"2024","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.cll.2025.01.012_bib48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clinms.2020.10.003","article-title":"Analysis of 17 fentanyls in plasma and blood by UPLC-MS\/MS with interpretation of findings in surgical and postmortem casework","volume":"18","author":"Danaceau","year":"2020","journal-title":"Clin Mass Spectrom"},{"issue":"4","key":"10.1016\/j.cll.2025.01.012_bib49","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1255\/ejms.761","article-title":"Identification of fentanyl, alfentanil, sufentanil, remifentanil and their major metabolites in human urine by liquid chromatography\/tandem mass spectrometry for doping control purposes","volume":"11","author":"Thevis","year":"2005","journal-title":"Eur J Mass Spectrom Chichester Engl"},{"issue":"1","key":"10.1016\/j.cll.2025.01.012_bib50","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1021\/acsomega.7b01536","article-title":"LC-MS\/MS-based method for the multiplex detection of 24 fentanyl analogues and metabolites in whole blood at sub ng mL\u20131 Concentrations","volume":"3","author":"Strayer","year":"2018","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.cll.2025.01.012_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68348-w","article-title":"Determination of 37 fentanyl analogues and novel synthetic opioids in hair by UHPLC-MS\/MS and its application to authentic cases","volume":"10","author":"Qin","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.cll.2025.01.012_bib52","article-title":"Detecting fentanyl analogs in urine using precursor ion scan mode","volume":"8","author":"Budelier","year":"2021","journal-title":"J Anal Toxicol"},{"issue":"9","key":"10.1016\/j.cll.2025.01.012_bib53","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s00204-016-1764-1","article-title":"High-resolution mass spectrometry in toxicology: current status and future perspectives","volume":"90","author":"Maurer","year":"2016","journal-title":"Arch Toxicol"},{"issue":"1","key":"10.1016\/j.cll.2025.01.012_bib54","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1373\/clinchem.2015.241315","article-title":"Comparison of information-dependent acquisition on a tandem quadrupole TOF vs a triple quadrupole linear ion trap mass spectrometer for broad-spectrum drug screening","volume":"62","author":"Thoren","year":"2016","journal-title":"Clin Chem"},{"key":"10.1016\/j.cll.2025.01.012_bib55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.toxlet.2019.12.007","article-title":"Application of the fentanyl analog screening kit toward the identification of emerging synthetic opioids in human plasma and urine by LC-QTOF","volume":"320","author":"Krajewski","year":"2020","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.cll.2025.01.012_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmsacl.2022.07.005","article-title":"Development and application of a High-Resolution mass spectrometry method for the detection of fentanyl analogs in urine and serum","volume":"26","author":"Zhang","year":"2022","journal-title":"J Mass Spectrom Adv Clin Lab"},{"key":"10.1016\/j.cll.2025.01.012_bib58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.forsciint.2019.02.006","article-title":"Data-independent screening method for 14 fentanyl analogs in whole blood and oral fluid using LC-QTOF-MS","volume":"297","author":"Palmquist","year":"2019","journal-title":"Forensic Sci Int"},{"issue":"1","key":"10.1016\/j.cll.2025.01.012_bib59","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00216-020-02994-x","article-title":"Targeted and untargeted detection of fentanyl analogues and their metabolites in hair by means of UHPLC-QTOF-HRMS","volume":"413","author":"Salomone","year":"2021","journal-title":"Anal Bioanal Chem"},{"issue":"2","key":"10.1016\/j.cll.2025.01.012_bib60","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/jalm\/jfac121","article-title":"Frequency of fentanyl analogs and metabolites detected by LC\u2013MS\/MS in clinical specimens","volume":"8","author":"Omosule","year":"2023","journal-title":"J Appl Lab Med"},{"issue":"24","key":"10.1016\/j.cll.2025.01.012_bib61","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMp2303120","article-title":"Xylazine \u2014 medical and public health imperatives","volume":"388","author":"Gupta","year":"2023","journal-title":"N Engl J Med"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271225000137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271225000137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T06:46:02Z","timestamp":1746773162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271225000137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0272271225000137"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2025.01.012","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of Fentanyl and Fentanyl Analogs","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2025.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}